Pavunalimab Biosimilar – Anti-LAG3;CTLA4 mAb – Research Grade

Reference:
Size

,

Isotype

Bispecific, IgG1, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product namePavunalimab Biosimilar - Anti-LAG3;CTLA4 mAb - Research Grade
SourceCAS 2329669-78-3
SpeciesHumanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3 week if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsPavunalimab,ANTI-CTLA-4/LAG-3 BISPECIFIC ANTIBODY XMAB22841, IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS LAG3 (LYMPHOCYTE ACTIVATING 3, LYMPHOCYTE-ACTIVATION 3, CD223)) AND ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4, CD152)), MONOCLONAL ANTIBODY, BISPECIFIC, XMAB-22841,LAG3;CTLA4,anti-LAG3;CTLA4
ReferencePX-TA1699
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeBispecific ,IgG1,Kappa
ClonalityMonoclonal Antibody

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Pavunalimab Biosimilar – Anti-LAG3;CTLA4 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CD223 Recombinant Protein
Antigen

CD223 Recombinant Protein

PX-P4110 500$
CD223 / LAG3, C-His, recombinant protein
Antigen

CD223 / LAG3, C-His, recombinant protein

PX-P5592 500$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products